Trilostane for Androgen-Independent Prostate Cancer

NCT00181597 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Prostate Adenocarcinoma

Interventions

DRUG: Trilostane
DRUG: Hydrocortisone

Sponsor

Genzyme, a Sanofi Company